← All organizations
Highest phase reached
Phase 4
First clinical trial
Dec 1, 2015Last known activity
May 31, 2024
Timeline
2010s
- Jan 1, 2015
Zuyderland Medisch Centrum— Founded
Drugs by trial phase (21 distinct, 12 trials)
Phase 4 (11 own, 0 via acquisition)
Phase 3 (1 own, 0 via acquisition)
Phase 1 (3 own, 0 via acquisition)
Other trials (6 own, 0 via acquisition)
Indications
Recent trials (19)
- NCT06287307Lead sponsorPhase 4May 31, 2024
- NCT06287307OfficialPhase 4May 31, 2024
- NCT05731973Lead sponsorN/AMar 31, 2023
- NCT05731973Overall official - principal investigatorN/AMar 31, 2023
- NCT05731973Reponsible party - principal investigatorN/AMar 31, 2023
- NCT05367089CollaboratorPhase 3Aug 22, 2022
- NCT05281380Lead sponsorN/ADec 1, 2021
- NCT05281380Overall official - principal investigatorN/ADec 1, 2021
- NCT04902625Lead sponsorPhase 4Jun 30, 2021
- NCT04688723Lead sponsorPhase 4Dec 23, 2020
- NCT04643301Lead sponsorN/ADec 21, 2020
- NCT04481256CollaboratorN/AOct 1, 2020
- NCT03846102Overall official - principal investigatorPhase 4Jan 28, 2019
- NCT03846102Lead sponsorPhase 4Jan 28, 2019
- NCT05693688CollaboratorPhase 4Dec 1, 2017
Details
- Founded
- Sittard-Geleen, NL Jan 1, 2015
- Last known activity
- May 31, 2024